quinazolines has been researched along with Leukemia P388 in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (60.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, G; Liu, P; Teng, X; Wang, Y; Zhu, W; Zhuang, Y | 1 |
| Antony, S; Gmeiner, WH; Kohlhagen, G; Liao, ZY; Pommier, Y; Sordet, O; Zhang, HL | 1 |
| Chen, J; Du, L; Duan, L; Fang, Y; Gu, QQ; Xin, ZH; Zhu, T; Zhu, WM | 1 |
| Elslager, EF; Johnson, JL; Werbel, LM | 1 |
| Baron, M; Cros, S; Giorgi-Renault, S; Mailliet, P; Paoletti, C; Renault, J; Voisin, E | 1 |
| Bontemps-Gracz, MM; Borowski, E; De Cesare, M; Dzieduszycka, M; Kuśnierczyk, H; Martelli, S; Pratesi, G; Radzikowski, C; Stefańska, B; Supino, R; Zunino, F | 1 |
| Baguley, BC; Bu, X; Deady, LW; Denny, WA; Finlay, GJ | 1 |
| Aschele, C; Bertino, JR; Nicolin, A; Rosso, R; Sobrero, A | 1 |
| Dykes, DJ; Elliott, WL; Howard, CT; Leopold, WR | 1 |
| Besserer, JA; Fry, DW; Klohs, WD; Steinkampf, RW | 1 |
| DeLap, RJ; Grillo-Lopez, AJ; Hoth, DF; King, SA; Leyland-Jones, B; O'Dwyer, PJ | 1 |
| Dykes, DJ; Griswold, DP; Leopold, WR | 1 |
| Atassi, G; Dykes, DJ; Harrison, SD; Kabbe, HJ; Narayanan, VL; Paull, KD; Plowman, J; Yoder, OC | 1 |
| Atassi, G; Dumont, P; Kabbe, HJ; Yoder, O | 1 |
| Baron, M; Cros, S; Delic, J; Gebel-Servolles, P; Giorgi-Renault, S; Paoletti, C; Renault, J | 1 |
15 other study(ies) available for quinazolines and Leukemia P388
| Article | Year |
|---|---|
New quinazolinone alkaloids within rare amino acid residue from coral-associated fungus, Aspergillus versicolor LCJ-5-4.
Topics: Alkaloids; Amino Acids, Cyclic; Animals; Anthozoa; Antifungal Agents; Antineoplastic Agents; Aspergillus; Candida albicans; Crystallography, X-Ray; HeLa Cells; Humans; Leukemia P388; Microbial Sensitivity Tests; Molecular Structure; Quinazolines | 2011 |
A novel polypyrimidine antitumor agent FdUMP[10] induces thymineless death with topoisomerase I-DNA complexes.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Death; DNA Damage; DNA Topoisomerases, Type I; DNA, Neoplasm; DNA, Single-Stranded; Drug Screening Assays, Antitumor; Fluorodeoxyuridylate; Fluorouracil; Leukemia P388; Mice; Quinazolines; Thiophenes; Thymidine; Thymidylate Synthase; Topoisomerase I Inhibitors | 2005 |
Aurantiomides A-C, quinazoline alkaloids from the sponge-derived fungus Penicillium aurantiogriseum SP0-19.
Topics: Alkaloids; Animals; Drug Screening Assays, Antitumor; Humans; Leukemia P388; Mice; Molecular Structure; Penicillium; Porifera; Quinazolines | 2007 |
Folate antagonists. 20. Synthesis and antitumor and antimalarial properties of trimetrexate and related 6-[(phenylamino)methyl]-2,4-quinazolinediamines.
Topics: Animals; Antimalarials; Antineoplastic Agents; Bacteria; Drug Resistance; Folic Acid Antagonists; Haplorhini; Leukemia L1210; Leukemia P388; Mice; Plasmodium falciparum; Quinazolines; Trimetrexate | 1983 |
Heterocyclic Quinones. 4. A new highly cytotoxic drug: 6,7-bis(1-aziridinyl)-5,8-quinazolinedione.
Topics: Animals; Antineoplastic Agents; Leukemia L1210; Leukemia P388; Mice; Mutagenicity Tests; Quinazolines; Sarcoma 180 | 1983 |
8,11-dihydroxy-6-[(aminoalkyl)amino]-7H-benzo[e]perimidin-7-ones with activity in multidrug-resistant cell lines: synthesis and antitumor evaluation.
Topics: Animals; Anthracenes; Antineoplastic Agents; Apoptosis; Cell Division; Cell Survival; Drug Resistance, Multiple; Humans; Leukemia P388; Mice; Mitoxantrone; Quinazolines; Tumor Cells, Cultured | 1999 |
Synthesis and cytotoxic activity of 7-oxo-7H-dibenz[f,ij]isoquinoline and 7-oxo-7H-benzo[e]perimidine derivatives.
Topics: Animals; Antineoplastic Agents; Cell Survival; Colonic Neoplasms; Doxorubicin; Drug Design; Drug Resistance, Neoplasm; Humans; Indicators and Reagents; Isoquinolines; Jurkat Cells; Leukemia P388; Lung Neoplasms; Mice; Mice, Inbred Strains; Models, Molecular; Molecular Conformation; Molecular Structure; Quinazolines; Structure-Activity Relationship; Tumor Cells, Cultured | 2001 |
Rapid development of resistance to antifolates in vitro: possible clinical implication.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Female; Folic Acid Antagonists; Leukemia P388; Methotrexate; Mice; Quinazolines; Trimetrexate; Tumor Cells, Cultured | 1991 |
Sequence and schedule-dependent synergy of trimetrexate in combination with 5-fluorouracil in vitro and in mice.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cell Survival; Cricetinae; Drug Administration Schedule; Drug Synergism; Fluorouracil; Folic Acid Antagonists; Leukemia P388; Mice; Phosphoribosyl Pyrophosphate; Quinazolines; Trimetrexate | 1989 |
Cross resistance of pleiotropically drug resistant P338 leukemia cells to the lipophilic antifolates trimetrexate and BW 301U.
Topics: Animals; Drug Resistance; Folic Acid Antagonists; Leukemia P388; Methotrexate; Mice; Pyrimidines; Quinazolines; Trimetrexate | 1986 |
Trimetrexate: clinical development of a nonclassical antifolate.
Topics: Animals; Biological Availability; Drug Administration Schedule; Drug Evaluation; Folic Acid Antagonists; Humans; Leukemia P388; Mice; Neoplasms; Quinazolines; Structure-Activity Relationship; Trimetrexate | 1987 |
Therapeutic synergy of trimetrexate (CI-898) in combination with doxorubicin, vincristine, cytoxan, 6-thioguanine, cisplatin, or 5-fluorouracil against intraperitoneally implanted P388 leukemia.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Synergism; Fluorouracil; Leukemia P388; Leukemia, Experimental; Mice; Quinazolines; Thioguanine; Trimetrexate; Vincristine | 1987 |
Preclinical antitumor activity of batracylin (NSC 320846).
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Colonic Neoplasms; Drug Evaluation, Preclinical; Injections, Intraperitoneal; Leukemia P388; Leukemia, Experimental; Mice; Mice, Inbred Strains; Quinazolines; Tumor Cells, Cultured | 1988 |
A new antitumour agent, batracylin, selected by a preclinical solid tumour model.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Colonic Neoplasms; Drug Screening Assays, Antitumor; Leukemia L1210; Leukemia P388; Melanoma, Experimental; Mice; Quinazolines | 1988 |
Heterocyclic quinones. XIII. Dimerization in the series of 5,8-quinazolinediones: synthesis and antitumor effects of bis(4-amino-5,8-quinazolinediones).
Topics: Animals; Antineoplastic Agents; Cell Survival; Chemical Phenomena; Chemistry; Leukemia P388; Mice; Quinazolines | 1988 |